UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Discover why indices rise or fall, examining earnings, macro data, and policy factors that shape broad market direction.
21,369 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Disney faces a cash flow decline even as streaming profitability edges higher. The market-wide tug-of-war keeps DIS a...
Insider trading activity can reveal how executives view their company’s future. This article digs into a real-world c...
A 20-year-old caller on The Ramsey Show is urged to cancel a $28,000 car loan after a rising debt load, underscoring ...
A high-profile Nvidia deal has propelled a semiconductor stock into the spotlight. This article breaks down whether t...
A major investment advisor just boosted its stake in the Invesco BulletShares 2027 Corporate Bond ETF by about $76 mi...
Jonathan Clements changed how everyday investors think about money. In this MiB-inspired reflection, Jason Zweig and ...
Boiling job growth can rattle markets, but a rapid rise in hiring doesn’t automatically trigger a crash. This guide b...
If you’re thinking about buying spacex, you’re not alone. Before you buy, ask three foundational questions that cover...
A fresh look at an internal code snippet raises questions about Anthropic’s plans for Fable 5, potentially tying week...
A looming funding cliff could shrink benefits for millions. This guide breaks down the numbers, the political dynamic...
A small nuclear energy company under $4B could ride a global revival in clean power. Learn how to evaluate this nucle...